Included in the formulation
АТХ:D.01.A.C.05 Isoconazole
G.01.A.F.07 Isoconazole
Pharmacodynamics:Inhibits the synthesis of ergosterol, changes the composition of membranes of microbial cells. Fungistatic effect on mold fungi, yeast and yeast-like fungi (including the causative agent of varicolored lichen), dermatophytes, as well as the causative agent of erythrasma.
Reduces the severity of inflammation in inflammatory and allergic skin diseases and eliminates sensations of itching, burning and pain.
Pharmacokinetics:The drug for topical application does not have a systemic effect.
Indications:It is used to treat fungal infections of the skin surface and genital area, it is used for dermatophytosis, microsporia, candidiasis.
I.B35-B49.B35 Dermatophytosis
I.B35-B49.B35.6 Epidermophytosis inguinal
I.B35-B49.B37 Candidiasis
I.B35-B49.B49 Mycosis, unspecified
XIV.N70-N77.N76 Other inflammatory diseases of the vagina and vulva
Contraindications:Individual intolerance, children's age (up to 1 month for cream, up to 18 years for suppositories).
Carefully:Increased individual sensitivity.
Pregnancy and lactation:Recommendations for FDA - Category B. It is used in pregnancy and lactation.
Dosing and Administration:Outer: the cream is applied to the affected skin twice a day. The course of treatment is at least 4 weeks.
Intravaginal: one suppository at night.
Side effects:Burning, itching, allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:Not described.
Special instructions:The introduction of vaginal suppositories during menstruation is contraindicated.
Avoid contact with isoconazole in the eyes.